Apellis Pharmaceuticals Inc (APLS) — Free Cash Flow Generation Index
Apellis Pharmaceuticals Inc (APLS) has a Free Cash Flow Generation Index of 1.00x as of September 2025. Free cash flow of $108.32 Million represents 1% of operating cash flow ($108.47 Million). See Apellis Pharmaceuticals Inc current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Apellis Pharmaceuticals Inc Free Cash Flow Generation Index (2025–2025)
Historical FCF Generation Index trend for Apellis Pharmaceuticals Inc across 1 annual periods. Explore Apellis Pharmaceuticals Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Apellis Pharmaceuticals Inc (2025–2025)
Year-by-year Free Cash Flow Generation Index for Apellis Pharmaceuticals Inc. For the full company profile including market capitalisation, see APLS market cap overview.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.99x | $45.01 Million | $45.33 Million | $313.00K | — |